The rise of non-tuberculosis mycobacterial lung disease

CN Ratnatunga, VP Lutzky, A Kupz, DL Doolan… - Frontiers in …, 2020 - frontiersin.org
The incidence and number of deaths from non-tuberculous mycobacterial (NTM) disease
have been steadily increasing globally. These lesser known “cousins” of Mycobacterium …

[HTML][HTML] British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)

CS Haworth, J Banks, T Capstick, AJ Fisher, T Gorsuch… - Thorax, 2017 - thorax.bmj.com
Background Since the publication of the British Thoracic Society (BTS) Guideline on the
'Management of opportunistic mycobacterial infections' in 2000, our understanding of the …

Cutaneous mycobacterial infections

C Franco-Paredes, LA Marcos… - Clinical microbiology …, 2018 - Am Soc Microbiol
Humans encounter mycobacterial species due to their ubiquity in different environmental
niches. In many individuals, pathogenic mycobacterial species may breach our first-line …

[HTML][HTML] Update on pulmonary disease due to non-tuberculous mycobacteria

JE Stout, WJ Koh, WW Yew - International Journal of Infectious Diseases, 2016 - Elsevier
Non-tuberculous mycobacteria (NTM) are emerging worldwide as significant causes of
chronic pulmonary infection, posing a number of challenges for both clinicians and …

[HTML][HTML] Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease

KM Pennington, A Vu, D Challener, CG Rivera… - Journal of Clinical …, 2021 - Elsevier
Non-tuberculous mycobacteria (NTM) is a collective name given to a group of more than 190
species of Mycobacterium. The clinical presentation for most NTM infections is non-specific …

Free-living amoebae as hosts for and vectors of intracellular microorganisms with public health significance

C Balczun, PL Scheid - Viruses, 2017 - mdpi.com
Free-living amoebae (FLA) are parasites within both humans and animals causing a wide
range of symptoms and act as hosts of, and vehicles for phylogenetically diverse …

The complexities and challenges of preventing and treating nontuberculous mycobacterial diseases

SL Baldwin, SE Larsen, D Ordway… - PLoS neglected …, 2019 - journals.plos.org
Seemingly innocuous nontuberculous mycobacteria (NTM) species, classified by their slow
or rapid growth rates, can cause a wide range of illnesses, from skin ulceration to severe …

Cannabinoid receptor type 2: a possible target in SARS-CoV-2 (CoV-19) infection?

F Rossi, C Tortora, M Argenziano, A Di Paola… - International Journal of …, 2020 - mdpi.com
In late December 2019, a novel coronavirus (SARS-CoV-2 or CoV-19) appeared in Wuhan,
China, causing a global pandemic. SARS-CoV-2 causes mild to severe respiratory tract …

Mycobacterium abscessus: It's Complex

HFM Abdelaal, ED Chan, L Young, SL Baldwin… - Microorganisms, 2022 - mdpi.com
Mycobacterium abscessus (M. abscessus) is an opportunistic pathogen usually colonizing
abnormal lung airways and is often seen in patients with cystic fibrosis. Currently, there is no …

Therapeutic developments for tuberculosis and nontuberculous mycobacterial lung disease

V Dartois, T Dick - Nature Reviews Drug Discovery, 2024 - nature.com
Tuberculosis (TB) drug discovery and development has undergone nothing short of a
revolution over the past 20 years. Successful public–private partnerships and sustained …